Details for New Drug Application (NDA): 020962
✉ Email this page to a colleague
The generic ingredient in EMLA is lidocaine; prilocaine. There are twenty-nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lidocaine; prilocaine profile page.
Summary for 020962
Tradename: | EMLA |
Applicant: | Astrazeneca |
Ingredient: | lidocaine; prilocaine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | DISC;TOPICAL | Strength | 2.5%;2.5% | ||||
Approval Date: | Feb 4, 1998 | TE: | RLD: | No |
Complete Access Available with Subscription